Tag: phenox

p64 MW Flow modulation device phenox

phenox launches p64 MW Flow modulation device with HPC coating technology

  phenox has announced the European launch of the new p64 MW Flow modulation device, intended for the treatment of intracranial aneurysms. The device received...
phenox wallaby

Phenox announces exclusive distribution agreement with Wallaby Medical for the Avenir...

Phenox announces that it has signed an exclusive distribution agreement with Wallaby Medical for commercialisation of the Avenir Detachable Coil System in the US...

High rate of aneurysm occlusion with p64 at mid- and long-term...

Investigators using the p64 Flow Modulation Device (Phenox) for the treatment of unruptured intracranial aneurysms at six centres have revealed that mid- and long-term...

ARTESp study of pREset device shows 62.5% positive clinical outcome after...

The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischaemic stroke. This was recently proven by four randomised controlled...

SITS Open stroke trial includes phenox pREset thrombectomy device

The phenox pREset and pREset LITE thrombectomy devices have been included in the study portfolio of the SITS Open clinical trial. Two other devices...

New device is “equivalent to, or better than” known flow diverters...

In the first study to be published reporting on endovascular aneurysm treatment with the p64 flow modulation device (Phenox), Francesco Briganti and colleagues have found that the device provides a safe procedure with no technical complications.

Phenox launches pToWin study to assess efficacy of pCONus bifurcation aneurysm...

Phenox GmbH has announced the start of the pToWin study after enrolling the first patient on 2 September, 2015. The prospective, multicentre, single-arm study...

Phenox receives CE mark approval for pCONus Bifurcation Aneurysm Implant

The pCONus implant for treatment of complex, wide neck intracranial bifurcation aneurysms has been granted the CE mark for commericalisation in Europe.

Phenox receives CE mark approval for p64 Flow Modulation Device

The p64 Flow Modulation Device is an intraluminal flow diverter for treatment of complex intracranial aneurysms and dissections.